Zealand Pharma Starts Phase 2 Trial of Obesity Drug Combination
Zealand Pharma announced the start of ZYNERGY, a Phase 2 dose-finding trial of petrelintide with enicepatide. The Roche-sponsored trial is expected to enroll 480 participants and assess weight change through week 40.
Story updates
06:05:05 AM UTC
SquawkNews
Zealand Pharma Announces Phase 2 Zynergy Trial Initiation Of Petrelintide With Enicepatide